S. Michael Rothenberg
Direttore/Membro del Consiglio presso TYRA BIOSCIENCES, INC.
Patrimonio netto: - $ in data 30/06/2024
Profilo
S.
Michael Rothenberg is an Independent Director at Tyra Biosciences, Inc. and the Chief Medical Officer at Insitro, Inc. He previously worked as the Vice President-Research & Development at Loxo Oncology, Inc. from 2015 to 2020.
Rothenberg completed his undergraduate degree at Yale University and holds a doctorate from Stanford University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
-.--% | 07/05/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Posizioni attive di S. Michael Rothenberg
| Società | Posizione | Inizio |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 07/05/2024 |
Insitro, Inc.
 Insitro, Inc. BiotechnologyHealth Technology Insitro, Inc. engages in engages in the discovery and development of drug products. Its approach include population scale data, cell-based disease models, biology at scale, cutting-edge machine learning, and predictive insights and new medicines. The company was founded by Daphne Koller and is headquartered in Portola Valley, CA. | Direttore Tecnico/Scientifico/R&S | 01/02/2024 |
Precedenti posizioni note di S. Michael Rothenberg
| Società | Posizione | Fine |
|---|---|---|
| LOXO ONCOLOGY INC | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
Formazione di S. Michael Rothenberg
| Stanford University School of Medicine | Doctorate Degree |
| Yale University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TYRA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Insitro, Inc. engages in engages in the discovery and development of drug products. Its approach include population scale data, cell-based disease models, biology at scale, cutting-edge machine learning, and predictive insights and new medicines. The company was founded by Daphne Koller and is headquartered in Portola Valley, CA. | Health Technology |
- Borsa valori
- Insiders
- S. Michael Rothenberg
